össur annual report2009 - Euroland
össur annual report2009 - Euroland
össur annual report2009 - Euroland
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Currently, Össur has favorable financing terms and no<br />
financial covenant issues.<br />
It is the intention to internationalize the debt structure<br />
of Össur.<br />
earnings per share<br />
earnings per share 2009 2008 change<br />
EPS diluted (US cents) 5.30 6.73 -21%<br />
Cash EPS diluted (US cents) 9.66 12.29 -21%<br />
cash floW<br />
Össur had a strong cash flow in 2009. The Company’s<br />
liquidity position has improved further and cash at the<br />
end of the year amounted to USD 80 million, compared<br />
to USD 31 million at the end of 2008.<br />
cash floW<br />
cash floW (USD ‘000) 2009 % of<br />
Sales<br />
2008 % of<br />
sales<br />
Working capital provided by operating activities 44,473 13% 58,070 17%<br />
Net cash provided by operating activities 69,155 21% 52,835 15%<br />
capital eXpenditure and investMents<br />
Capital investments amounted to USD 9.7 million or<br />
2.9% of sales, compared to USD 7.8 million and 2.2%<br />
of sales in the same period of 2008. Capital investments<br />
continue to be in line with the Company’s guidance of<br />
2.5-3.5%.<br />
split betWeen currencies 2009<br />
currency split incoMe cost<br />
USD 48.2% 50.9%<br />
EUR 35.0% 29.7%<br />
ISK 0.3% 9.1%<br />
Other European currencies 16.5% 10.3%<br />
<strong>annual</strong> report 09<br />
54<br />
sales by segMent<br />
usd ‘000 2009 % of<br />
sales<br />
bracing &<br />
supports<br />
groWth<br />
usd<br />
161,732 49% -10% -6%<br />
prosthetics 148,513 45% 4% 8%<br />
coMpression<br />
therapy<br />
18,159 5% -10% -5%<br />
groWth<br />
lcy<br />
other 2,176 1% -57% -53%<br />
total 330,580 100% -5% -1%
Change language